Editorial
doi: 10.1161/JAHA.117.005737.
Warning About Shortcuts in Drug Development
Affiliations
- PMID: 28325714
- PMCID: PMC5524047
- DOI: 10.1161/JAHA.117.005737
Item in Clipboard
Editorial
Warning About Shortcuts in Drug Development
J Am Heart Assoc.
.
No abstract available
Keywords: Editorials; biomarkers; ethics and policy.
Comment on
-
Two Decades of Cardiovascular Trials With Primary Surrogate Endpoints: 1990-2011.J Am Heart Assoc. 2017 Mar 21;6(3):e005285. doi: 10.1161/JAHA.116.005285. J Am Heart Assoc. 2017. PMID: 28325713 Free PMC article. Review.
Similar articles
-
A study of warning letters issued to clinical investigators by the United States Food and Drug Administration.Clin Invest Med. 2004 Jun;27(3):129-34. Clin Invest Med. 2004. PMID: 15305804
-
Inside the black box: current policies and concerns with the United States Food and Drug Administration's highest drug safety warning system.Curr Opin Anaesthesiol. 2010 Jun;23(3):423-7. doi: 10.1097/aco.0b013e328338c9f7. Curr Opin Anaesthesiol. 2010. PMID: 20446348 Review.
-
FDA response to droperidol black box warning editorials.Anesth Analg. 2008 May;106(5):1585. doi: 10.1213/ane.0b013e3181693844. Anesth Analg. 2008. PMID: 18420886 No abstract available.
-
A study of warning letters issued to institutional review boards by the United States Food and Drug Administration.Clin Invest Med. 2004 Dec;27(6):316-23. Clin Invest Med. 2004. PMID: 15675112
-
Behind the Black Box: The Evidence for the U.S. Food and Drug Administration Warning about the Risk of General Anesthesia in Children Younger than 3 Years.Plast Reconstr Surg. 2017 Oct;140(4):787-792. doi: 10.1097/PRS.0000000000003691. Plast Reconstr Surg. 2017. PMID: 28953732 Review.
Cited by
-
Surrogate disease markers as substitutes for chronic disease outcomes in studies of diet and chronic disease relations.Am J Clin Nutr. 2017 Nov;106(5):1175-1189. doi: 10.3945/ajcn.117.164046. Epub 2017 Oct 11. Am J Clin Nutr. 2017. PMID: 29021287 Free PMC article.
References
-
- Kaplan S. Trump considers naming FDA chief who would radically overhaul the agency. December 7, 2016. Available at: https://www.statnews.com/2016/12/07/trump-fda-oneill/. Accessed February 21, 2017.
-
- Bikdeli B, Punnanithinont N, Akram Y, Lee I, Desai N, Ross J, Krumholz H. Two decades of cardiovascular trials with primary surrogate endpoints: 1990–2011. J Am Heart Assoc. 2017;6:e005285 DOI: 10.1161/JAHA.116.005285. - DOI - PMC - PubMed
-
- Smietana K, Siatkowski M, Moller M. Trends in clinical success rates. Nat Rev Drug Discov. 2016;15:379–380. - PubMed
-
- FDA‐NIH Working Group . BEST (Biomarkers, EndpointS, and other Tools) resource. Available at: https://www.ncbi.nlm.nih.gov/books/NBK326791/. Accessed February 20, 2017.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
